Blue Ridge Capital’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BG
Blue Ridge Capital's AGN Position: Q1 2018 in Review
Blue Ridge Capital sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 215,000 shares — an estimated $35.2M sold.
Blue Ridge Capital first reported a position in AGN in Q4 2013 and held it in 17 quarters. The position peaked at $625M in Q4 2015. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.
- Blue Ridge Capital reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
- Blue Ridge Capital sold 215,000 Allergan plc shares in Q1 2018, an estimated $35.2M.
- Blue Ridge Capital first reported a position in Allergan plc in Q4 2013 and held it in 17 quarters.
- Blue Ridge Capital's Allergan plc position peaked at $625M in Q4 2015.
- 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.
Based on Blue Ridge Capital's 13F filing for Q1 2018.